Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology has emerged as an adaptable instrument for several uses. The CRISPR–Cas system employs Cas proteins and programmable RNA molecules to guide the recognition and cleavage of specific DNA regions, permitting accurate genome e...

Full description

Saved in:
Bibliographic Details
Main Authors: Mushtak T. S. Al-Ouqaili, Amna Ahmad, Noor A. Jwair, Farah Al-Marzooq
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2025.1588446/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849717495252910080
author Mushtak T. S. Al-Ouqaili
Amna Ahmad
Noor A. Jwair
Farah Al-Marzooq
author_facet Mushtak T. S. Al-Ouqaili
Amna Ahmad
Noor A. Jwair
Farah Al-Marzooq
author_sort Mushtak T. S. Al-Ouqaili
collection DOAJ
description Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology has emerged as an adaptable instrument for several uses. The CRISPR–Cas system employs Cas proteins and programmable RNA molecules to guide the recognition and cleavage of specific DNA regions, permitting accurate genome editing. It is derived from the bacterial immune system and allows for accurate and efficient modification of DNA sequences. This technique provides unparalleled gene editing, control, and precise alteration opportunities. This review aims to offer a comprehensive update of the core concepts of the CRISPR–Cas system and recent progress, while also providing an overview of the significant applications in diverse fields such as microbiology and medicine. The CRISPR–Cas9 gene editing technique has facilitated substantial advancements in comprehending gene function, simulating diseases, and creating innovative therapeutics. CRISPR-based therapeutics present a hopeful prospect for addressing intricate ailments, including genetic disorders, malignancies, and infectious diseases, as they serve as viable substitutes for conventional pharmaceuticals. In microbiology, this method serves as a diagnostic and therapeutic tool that proves highly efficient in eliminating bacteria that have developed resistance to various antibiotics. Despite its significant potential, CRISPR encounters ethical, safety, and regulatory obstacles that necessitate meticulous deliberation. Concerns regarding off-target effects, poor delivery to target tissues, and unwanted side effects emphasize the necessity to thoroughly examine the technology. It is necessary to balance the advantages and difficulties CRISPR presents. Consequently, more rigorous preclinical and clinical experiments are essential before using it in humans.
format Article
id doaj-art-6f7fec55c72d4e2fada831789a9c5bf2
institution DOAJ
issn 2235-2988
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-6f7fec55c72d4e2fada831789a9c5bf22025-08-20T03:12:38ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882025-05-011510.3389/fcimb.2025.15884461588446Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicineMushtak T. S. Al-Ouqaili0Amna Ahmad1Noor A. Jwair2Farah Al-Marzooq3Department of Microbiology, College of Medicine, University of Anbar, Ramadi, Anbar Governorate, IraqDepartment of Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab EmiratesAnbar Health Directorate, Department of Public Health, Anbar Governorate, Ramadi, IraqDepartment of Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab EmiratesClustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology has emerged as an adaptable instrument for several uses. The CRISPR–Cas system employs Cas proteins and programmable RNA molecules to guide the recognition and cleavage of specific DNA regions, permitting accurate genome editing. It is derived from the bacterial immune system and allows for accurate and efficient modification of DNA sequences. This technique provides unparalleled gene editing, control, and precise alteration opportunities. This review aims to offer a comprehensive update of the core concepts of the CRISPR–Cas system and recent progress, while also providing an overview of the significant applications in diverse fields such as microbiology and medicine. The CRISPR–Cas9 gene editing technique has facilitated substantial advancements in comprehending gene function, simulating diseases, and creating innovative therapeutics. CRISPR-based therapeutics present a hopeful prospect for addressing intricate ailments, including genetic disorders, malignancies, and infectious diseases, as they serve as viable substitutes for conventional pharmaceuticals. In microbiology, this method serves as a diagnostic and therapeutic tool that proves highly efficient in eliminating bacteria that have developed resistance to various antibiotics. Despite its significant potential, CRISPR encounters ethical, safety, and regulatory obstacles that necessitate meticulous deliberation. Concerns regarding off-target effects, poor delivery to target tissues, and unwanted side effects emphasize the necessity to thoroughly examine the technology. It is necessary to balance the advantages and difficulties CRISPR presents. Consequently, more rigorous preclinical and clinical experiments are essential before using it in humans.https://www.frontiersin.org/articles/10.3389/fcimb.2025.1588446/fullgene editingCRISPR-CasCas9innovative therapeuticsinfections
spellingShingle Mushtak T. S. Al-Ouqaili
Amna Ahmad
Noor A. Jwair
Farah Al-Marzooq
Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine
Frontiers in Cellular and Infection Microbiology
gene editing
CRISPR-Cas
Cas9
innovative therapeutics
infections
title Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine
title_full Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine
title_fullStr Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine
title_full_unstemmed Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine
title_short Harnessing bacterial immunity: CRISPR-Cas system as a versatile tool in combating pathogens and revolutionizing medicine
title_sort harnessing bacterial immunity crispr cas system as a versatile tool in combating pathogens and revolutionizing medicine
topic gene editing
CRISPR-Cas
Cas9
innovative therapeutics
infections
url https://www.frontiersin.org/articles/10.3389/fcimb.2025.1588446/full
work_keys_str_mv AT mushtaktsalouqaili harnessingbacterialimmunitycrisprcassystemasaversatiletoolincombatingpathogensandrevolutionizingmedicine
AT amnaahmad harnessingbacterialimmunitycrisprcassystemasaversatiletoolincombatingpathogensandrevolutionizingmedicine
AT noorajwair harnessingbacterialimmunitycrisprcassystemasaversatiletoolincombatingpathogensandrevolutionizingmedicine
AT farahalmarzooq harnessingbacterialimmunitycrisprcassystemasaversatiletoolincombatingpathogensandrevolutionizingmedicine